Exploring Immersion Coating as a Cost-Effective Method for Small-Scale Production of Enteric-Coated Gelatin Capsules
The coating process for solid dosage forms is widely used in the pharmaceutical industry but presents challenges for small-scale production, needed in personalized medicine and clinical or galenic settings. This study aimed to evaluate immersion coating, a cost-effective small-scale method, for ente...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_bc4e90a10c2f42ef8bf8e01c4ca92c6a | ||
042 | |a dc | ||
100 | 1 | 0 | |a Beatrice Sabbatini |e author |
700 | 1 | 0 | |a Diego Romano Perinelli |e author |
700 | 1 | 0 | |a Giovanni Filippo Palmieri |e author |
700 | 1 | 0 | |a Marco Cespi |e author |
700 | 1 | 0 | |a Giulia Bonacucina |e author |
245 | 0 | 0 | |a Exploring Immersion Coating as a Cost-Effective Method for Small-Scale Production of Enteric-Coated Gelatin Capsules |
260 | |b MDPI AG, |c 2024-03-01T00:00:00Z. | ||
500 | |a 10.3390/ph17040433 | ||
500 | |a 1424-8247 | ||
520 | |a The coating process for solid dosage forms is widely used in the pharmaceutical industry but presents challenges for small-scale production, needed in personalized medicine and clinical or galenic settings. This study aimed to evaluate immersion coating, a cost-effective small-scale method, for enteric-coated gelatin capsules using standard equipment. Two enteric coating polymers and different polymer concentrations were tested, along with API solubility. Results were compared with commercially available enteric capsule shells. Successful preparation of enteric coating capsules via immersion necessitates a comprehensive grasp of API and enteric polymer behavior. However, utilizing commercially available enteric capsule shells does not guarantee ease or robustness, as their efficacy hinges on the attributes of the active ingredient and excipients. Notably, coating with Eudragit S100 stands out for its superior process robustness, requiring minimal or no development time, thus representing the best option for small-scale enteric capsule production. | ||
546 | |a EN | ||
690 | |a Eudragit | ||
690 | |a hypromellose acetate succinate | ||
690 | |a paracetamol | ||
690 | |a tramadol HCl | ||
690 | |a enteric capsules | ||
690 | |a enteric coating | ||
690 | |a Medicine | ||
690 | |a R | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceuticals, Vol 17, Iss 4, p 433 (2024) | |
787 | 0 | |n https://www.mdpi.com/1424-8247/17/4/433 | |
787 | 0 | |n https://doaj.org/toc/1424-8247 | |
856 | 4 | 1 | |u https://doaj.org/article/bc4e90a10c2f42ef8bf8e01c4ca92c6a |z Connect to this object online. |